---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-059084"
form_type: "8-K"
ticker: "CTOR"
cik: "0001851484"
company_name: "CITIUS ONCOLOGY, INC."
filed_at: "2025-06-27T23:59:59+00:00"
generated_at: "2026-05-18T16:30:57.880888+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Citius Oncology regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq compliance notice on June 26, 2025, for Listing Rule 5550(a)(2).
- Common stock closing bid price was $1.00+ for 12 consecutive trading days (June 6–24, 2025).
- Nasdaq considers the bid price deficiency matter closed.
- Company avoids delisting; its common stock remains listed on Nasdaq Capital Market.
- Ticker CTOR; compliance regained after previous bid price shortfall.

## SEC filing metadata
- accession: 0001213900-25-059084
- form_type: 8-K
- ticker: CTOR
- cik: 0001851484
- company_name: CITIUS ONCOLOGY, INC.
- filed_at: 2025-06-27T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851484/000121390025059084/0001213900-25-059084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851484/000121390025059084/ea024719201-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-059084
- JSON: https://secwatch.observer/filing/0001213900-25-059084.json
- Plain text: https://secwatch.observer/filing/0001213900-25-059084.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.